Saturday, September 14, 2019

   
 

Educational Sessions

Faculty

Room 202 Genomic Predispositions to MGUS/MM S Kristinsson/M Went
Room 203 Genomic Landscape of MM
R Fonseca/B Walker
Room 204 Cell Free DNA Assays for MM Diagnosis and Evolution I Ghobrial/J Lohr
Room 205 Functional Genomic Studies of MM C Mitsiades/R Carrasco
Room 210 Molecular Driven Treatment Approach to MM F Davies/J Keats
Room 308 CD38 Monoclonal Antibody Therapy in MM: Mechanistic Insights and Resistance T Plesner/M Gatt
Room 309 MRD Assessment in MM R Owen/S Oliva
Room 310 Prevention and Management of Drug Related Toxicities in MM H Ludwig/R Vij
Room 311 Novel targets and agents for MM E Ocio/L Boise
Room 312 Imaging Techniques and Applications in MM E Zamagni/J Hillengass
Room 313 New Concepts in Bone Disease Control for MM D Roodman/E Terpos
   

Plenary Session

Faculty

Celgene Supported Plenary Session

 
Session Chairs N Raje/E Staudtmaeur
Overview of Car T Cell Approaches to MM A Cohen
Cytokine Release Syndrome N Shah
Optimizing Car T cell therapy in MM E Smith
Mechanisms underlying non-reponse and resistance to Car T cells TBD
Maintaining Car T Cell Response N Van De Donk
   
Treatment of Previously Treated Myeloma  
Session Chairs S Kumar/M Boccadoro
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   
Myeloma Transplant and Maintenance Strategies M Attal/TBD
Session Chairs  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   

Expositions, Porter Session and Lunch

   
Amyloidosis and Light Chain Deposition Disease  
Session Chairs G Merlini/M Gertz
Diagnosis and Workup of Amyloidosis M Gertz
LC Amyloidosis Treatment Approach G Merlini
Role of SCT in LC Amyloid Management V Sanchorawala
Novel treatment options for LC Amyloid R Comenzo
Management of LCDD A Dispenzieri
   
Waldenstrom's Macroglobulinemia  
Session Chairs I Ghobrial/R Garcia Sanz
Genomic Basis Z Hunter
Precursor Conditions R Kyle
Frontline Approaches to Treatment E Kastritis
Treatment of Relapsed/Refractory Disease J Castillo
Novel agents and approaches S Treon
   
Keynote Addresses  
Immune dysfunction in myeloma pathogenesis Q Yi
Do degrons represent the next therapeutic advance for MM? N Gray
   

Closing Ceremonies and Award Presentations
at the Boston Museum of Fine Arts

 

Workshop Organizers

Christopher Patterson
IMW 17 Secretariat

Dana Farber Cancer Institute
Mayor 548
450 Brookline Avenue
Boston, MA 02215
+1 617 632 6285

cpatterson1@partners.org

Join the IMS Today

Enjoy the

benefits of Membership

in the

International Myeloma Society

Become a Member Today

Housing & Registration

Accommodations


c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
+ 1 703-449-6418 (International)

Reserve Now

Contact the IMS

International Myeloma Society

Lisa Sikkink, IMS Assistant

International Myeloma Society
Mayo Clinic
Siebens 6-60
200 First Street SW
Rochester, MN 55905
+1 507 284 3725

adminassistant@myelomasociety.org